A detailed history of Israel Englander (Millennium Management LLC) transactions in Catalent, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,517,953 shares of CTLT stock, worth $276 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,517,953
Previous 4,079,964 10.74%
Holding current value
$276 Million
Previous $229 Million 19.28%
% of portfolio
0.14%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $24.6 Million - $26.7 Million
437,989 Added 10.74%
4,517,953 $274 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $121 Million - $129 Million
2,259,784 Added 124.15%
4,079,964 $229 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $76.1 Million - $107 Million
1,787,022 Added 5389.41%
1,820,180 $103 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $16.2 Million - $23.5 Million
-504,229 Reduced 93.83%
33,158 $1.49 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $48 Million - $101 Million
-1,506,441 Reduced 73.71%
537,387 $23.3 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $30.6 Million - $49.9 Million
672,627 Added 49.05%
2,043,828 $134 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $31 Million - $60.7 Million
749,648 Added 120.61%
1,371,201 $61.7 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $20.9 Million - $32.7 Million
289,331 Added 87.09%
621,553 $45 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $3.58 Million - $4.68 Million
-41,024 Reduced 10.99%
332,222 $35.6 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $47.6 Million - $62.9 Million
-505,596 Reduced 57.53%
373,246 $41.4 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $15.6 Million - $18.1 Million
130,202 Added 17.39%
878,842 $113 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $25.2 Million - $32.9 Million
-230,970 Reduced 23.58%
748,640 $99.6 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $5.09 Million - $5.87 Million
-50,755 Reduced 4.93%
979,610 $106 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $21 Million - $25.9 Million
206,413 Added 25.05%
1,030,365 $109 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $3.58 Million - $4.39 Million
41,684 Added 5.33%
823,952 $85.7 Million
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $23.7 Million - $30.1 Million
-325,669 Reduced 29.39%
782,268 $67 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $34.7 Million - $57.1 Million
722,983 Added 187.81%
1,107,937 $81.2 Million
Q1 2020

May 14, 2020

SELL
$36.95 - $62.95 $6.09 Million - $10.4 Million
-164,694 Reduced 29.96%
384,954 $20 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $21.3 Million - $25.6 Million
452,678 Added 466.82%
549,648 $30.9 Million
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $1.89 Million - $2.31 Million
39,819 Added 69.67%
96,970 $4.62 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $610,021 - $842,314
-15,538 Reduced 21.38%
57,151 $3.1 Million
Q1 2019

May 14, 2019

SELL
$29.84 - $43.92 $10.3 Million - $15.2 Million
-345,196 Reduced 82.61%
72,689 $2.95 Million
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $149,600 - $231,468
4,995 Added 1.21%
417,885 $13 Million
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $31.6 Million - $35.9 Million
-787,377 Reduced 65.6%
412,890 $18.8 Million
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $45.4 Million - $49.9 Million
1,172,638 Added 4244.23%
1,200,267 $50.3 Million
Q1 2018

May 15, 2018

SELL
$39.4 - $47.39 $20.3 Million - $24.4 Million
-515,441 Reduced 94.91%
27,629 $1.13 Million
Q4 2017

Feb 14, 2018

SELL
$37.27 - $43.02 $53.6 Million - $61.9 Million
-1,438,903 Reduced 72.6%
543,070 $22.3 Million
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $66.9 Million - $82.6 Million
1,981,973
1,981,973 $79.1 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.